S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
NASDAQ:JRSH

Jerash Holdings (US) Stock Forecast, Price & News

$5.35
+0.04 (+0.75 %)
(As of 12/4/2020 04:30 PM ET)
Add
Compare
Today's Range
$5.34
Now: $5.35
$5.47
50-Day Range
$4.67
MA: $4.96
$5.43
52-Week Range
$3.60
Now: $5.35
$7.14
Volume20,105 shs
Average Volume17,336 shs
Market Capitalization$60.59 million
P/E Ratio12.74
Dividend Yield3.77%
Beta0.63
Jerash Holdings (US), Inc., through its subsidiaries, manufactures and exports customized and ready-made sports and outerwear. The company offers jackets, polo shirts, t-shirts, pants, and shorts made from knitted fabric. It serves various brand-name retailers in the United States, Jordan, and internationally. The company was founded in 2016 and is based in Fairfield, New Jersey.

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 1.9Dividend Strength: 1.7Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.83 out of 5 stars


Industry, Sector and Symbol

Industry Apparel, finished products from fabrics & similar materials
Sub-IndustryN/A
Current SymbolNASDAQ:JRSH
CUSIPN/A
CIKN/A
Phone214-906-0065
Employees4,100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$93.02 million
Cash Flow$0.72 per share
Book Value$5.04 per share

Profitability

Net Income$6.46 million

Miscellaneous

Market Cap$60.59 million
Next Earnings Date2/11/2021 (Estimated)
OptionableNot Optionable
$5.35
+0.04 (+0.75 %)
(As of 12/4/2020 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive JRSH News and Ratings via Email

Sign-up to receive the latest news and ratings for JRSH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Jerash Holdings (US) (NASDAQ:JRSH) Frequently Asked Questions

How has Jerash Holdings (US)'s stock price been impacted by Coronavirus?

Jerash Holdings (US)'s stock was trading at $5.79 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, JRSH shares have decreased by 7.6% and is now trading at $5.35.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Jerash Holdings (US)?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Jerash Holdings (US) in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Jerash Holdings (US)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Jerash Holdings (US)?

Wall Street analysts have given Jerash Holdings (US) a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Jerash Holdings (US) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Jerash Holdings (US)'s next earnings date?

Jerash Holdings (US) is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Jerash Holdings (US)
.

How were Jerash Holdings (US)'s earnings last quarter?

Jerash Holdings (US), Inc. (NASDAQ:JRSH) issued its earnings results on Thursday, November, 12th. The company reported $0.23 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.15 by $0.08. The business had revenue of $27.09 million for the quarter. Jerash Holdings (US) had a net margin of 5.49% and a return on equity of 8.45%.
View Jerash Holdings (US)'s earnings history
.

How often does Jerash Holdings (US) pay dividends? What is the dividend yield for Jerash Holdings (US)?

Jerash Holdings (US) announced a quarterly dividend on Tuesday, November 3rd. Shareholders of record on Monday, November 16th will be given a dividend of $0.05 per share on Monday, November 23rd. This represents a $0.20 annualized dividend and a yield of 3.74%. The ex-dividend date is Friday, November 13th.
View Jerash Holdings (US)'s dividend history
.

What guidance has Jerash Holdings (US) issued on next quarter's earnings?

Jerash Holdings (US) issued an update on its FY 2021 Pre-Market earnings guidance on Thursday, November, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $85-85 million, compared to the consensus revenue estimate of $82.42 million.

What price target have analysts set for JRSH?

2 Wall Street analysts have issued 1 year price objectives for Jerash Holdings (US)'s stock. Their forecasts range from $8.00 to $9.00. On average, they expect Jerash Holdings (US)'s share price to reach $8.33 in the next twelve months. This suggests a possible upside of 55.8% from the stock's current price.
View analysts' price targets for Jerash Holdings (US)
.

Are investors shorting Jerash Holdings (US)?

Jerash Holdings (US) saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 2,700 shares, an increase of 68.8% from the October 31st total of 1,600 shares. Based on an average daily trading volume, of 31,700 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.1% of the shares of the stock are short sold.
View Jerash Holdings (US)'s Short Interest
.

Who are some of Jerash Holdings (US)'s key competitors?

What other stocks do shareholders of Jerash Holdings (US) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jerash Holdings (US) investors own include Pfizer (PFE), Primo Water (PRMW), AbbVie (ABBV), Ampio Pharmaceuticals (AMPE), Applied DNA Sciences (APDN), Brainstorm Cell Therapeutics (BCLI), Bionano Genomics (BNGO), ChromaDex (CDXC), Chimerix (CMRX) and Cinemark (CNK).

Who are Jerash Holdings (US)'s key executives?

Jerash Holdings (US)'s management team includes the following people:
  • Mr. Lin Hung Choi, Chairman, CEO, Pres & Treasurer (Age 58, Pay $300k)
  • Mr. Gilbert Kwong-Yiu Lee, Chief Financial Officer (Age 62, Pay $119.94k)
  • Ms. Yang Wei, VP, Sec. & Director (Age 38, Pay $66.1k)
  • Mr. Tsze Lun Ng, Advisor & Head of Marketing (Age 65)

What is Jerash Holdings (US)'s stock symbol?

Jerash Holdings (US) trades on the NASDAQ under the ticker symbol "JRSH."

Who are Jerash Holdings (US)'s major shareholders?

Jerash Holdings (US)'s stock is owned by a number of institutional and retail investors. Top institutional shareholders include Royce & Associates LP (1.17%) and 1492 Capital Management LLC (0.18%).
View institutional ownership trends for Jerash Holdings (US)
.

Which institutional investors are selling Jerash Holdings (US) stock?

JRSH stock was sold by a variety of institutional investors in the last quarter, including 1492 Capital Management LLC, and Royce & Associates LP.
View insider buying and selling activity for Jerash Holdings (US)
.

How do I buy shares of Jerash Holdings (US)?

Shares of JRSH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Jerash Holdings (US)'s stock price today?

One share of JRSH stock can currently be purchased for approximately $5.35.

How big of a company is Jerash Holdings (US)?

Jerash Holdings (US) has a market capitalization of $60.59 million and generates $93.02 million in revenue each year. The company earns $6.46 million in net income (profit) each year or $0.57 on an earnings per share basis. Jerash Holdings (US) employs 4,100 workers across the globe.

What is Jerash Holdings (US)'s official website?

The official website for Jerash Holdings (US) is www.jerashholdings.com.

How can I contact Jerash Holdings (US)?

Jerash Holdings (US)'s mailing address is 260 EAST MAIN STREET SUITE 2706, ROCHESTER NY, 14604. The company can be reached via phone at 214-906-0065 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.